{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:03:13Z","timestamp":1777896193161,"version":"3.51.4"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI122108"],"award-info":[{"award-number":["R21 AI122108"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.01195","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T04:35:18Z","timestamp":1528173318000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["An Improved Tobacco Mosaic Virus (TMV)-Conjugated Multiantigen Subunit Vaccine Against Respiratory Tularemia"],"prefix":"10.3389","volume":"9","author":[{"given":"Ahd A.","family":"Mansour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukalyani","family":"Banik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragavan V.","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hardeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison A.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra S.","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2013.00109","article-title":"Neutrophils: potential therapeutic targets in tularemia?","volume":"3","author":"Allen","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011060","article-title":"Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis.","volume":"5","author":"Apicella","year":"2010","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1016\/j.vaccine.2016.09.063","article-title":"Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.","volume":"34","author":"Arnaboldi","year":"2016","journal-title":"Vaccine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050460","article-title":"A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.","volume":"7","author":"Ashtekar","year":"2012","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1016\/j.vaccine.2008.07.051","article-title":"An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.","volume":"26","author":"Bakshi","year":"2008","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130858","article-title":"Development of a multivalent subunit vaccine against tularemia using Tobacco Mosaic Virus (TMV) based delivery system.","volume":"10","author":"Banik","year":"2015","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1128\/IAI.01606-06","article-title":"Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.","volume":"75","author":"Baron","year":"2007","journal-title":"Infect. Immun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"832","DOI":"10.4161\/hv.10297","article-title":"Vaccines against tularemia.","volume":"5","author":"Barry","year":"2009","journal-title":"Hum. Vaccin"},{"key":"B9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1699-0463.1995.tb01085.x","article-title":"Live tularemia vaccine but not proteins purified from Francisella tularensis can confer protection against lethal Listeria infection in mice.","volume":"103","author":"Belyi","year":"1995","journal-title":"APMIS"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.4049\/jimmunol.0803242","article-title":"Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis.","volume":"182","author":"Bitsaktsis","year":"2009","journal-title":"J. Immunol."},{"key":"B11","first-page":"1126","article-title":"[Tularemia, a potential bioterrorism weapon].","volume":"32","author":"Bossi","year":"2003","journal-title":"Presse Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/infdis\/135.1.55","article-title":"Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia.","volume":"135","author":"Burke","year":"1977","journal-title":"J. Infect. Dis."},{"key":"B13","first-page":"181","article-title":"Tularemia\u2013United States, 1990-2000.","volume":"51","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B14","first-page":"963","article-title":"Tularemia - United States, 2001-2010.","volume":"62","year":"2013","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2010.00138","article-title":"The francisella intracellular life cycle: toward molecular mechanisms of intracellular survival and proliferation.","volume":"1","author":"Chong","year":"2010","journal-title":"Front. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004439","article-title":"Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates.","volume":"10","author":"Chu","year":"2014","journal-title":"PLoS Pathog."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00427","article-title":"Modulation of primary immune response by different vaccine adjuvants.","volume":"7","author":"Ciabattini","year":"2016","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1016\/S0264-410X(02)00345-6","article-title":"Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen.","volume":"20","author":"Conlan","year":"2002","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"vi","DOI":"10.1016\/j.det.2004.03.009","article-title":"Tularemia: the disease and the weapon.","volume":"22","author":"Cronquist","year":"2004","journal-title":"Dermatol. Clin."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1126\/science.8456300","article-title":"Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.","volume":"259","author":"Dalton","year":"1993","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002494","article-title":"Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen. F. tularensis LVS.","volume":"8","author":"De Pascalis","year":"2012","journal-title":"PLoS Pathog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"23844","DOI":"10.1074\/jbc.M113.490086","article-title":"Repression of inflammasome by Francisella tularensis during early stages of infection.","volume":"288","author":"Dotson","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4269\/ajtmh.2008.78.586","article-title":"Ecoepidemiology of tularemia in the southcentral United States.","volume":"78","author":"Eisen","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.micinf.2009.09.012","article-title":"Survival of secondary lethal systemic Francisella LVS challenge depends largely on interferon gamma.","volume":"12","author":"Elkins","year":"2010","journal-title":"Microbes Infect."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/pmic.200600985","article-title":"Immunodominant Francisella tularensis antigens identified using proteome microarray.","volume":"7","author":"Eyles","year":"2007","journal-title":"Proteomics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1056\/NEJMoa011374","article-title":"An outbreak of primary pneumonic tularemia on Martha\u2019s Vineyard.","volume":"345","author":"Feldman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1086\/518611","article-title":"Francisella tularensis has a significant extracellular phase in infected mice.","volume":"196","author":"Forestal","year":"2007","journal-title":"J. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1016\/S0264-410X(01)00189-X","article-title":"Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.","volume":"19","author":"Fulop","year":"2001","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0264-410X(95)93311-V","article-title":"Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis.","volume":"13","author":"Golovliov","year":"1995","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5152\/balkanmedj.2014.13117","article-title":"Epidemiology of tularemia.","volume":"31","author":"Gurcan","year":"2014","journal-title":"Balkan Med. J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/pmic.200401123","article-title":"Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia.","volume":"5","author":"Havlasova","year":"2005","journal-title":"Proteomics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/1615-9861(200207)2:7<857::AID-PROT857>3.0.CO;2-L","article-title":"Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain.","volume":"2","author":"Havlasova","year":"2002","journal-title":"Proteomics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1016\/j.vaccine.2011.07.075","article-title":"Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.","volume":"29","author":"Hickey","year":"2011","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000232426","article-title":"Antigenic composition of a vaccine strain of Francisella tularensis.","volume":"61","author":"Holm","year":"1980","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1128\/JB.01505-06","article-title":"Characterization of Francisella tularensis outer membrane proteins.","volume":"189","author":"Huntley","year":"2007","journal-title":"J. Bacteriol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1128\/IAI.00374-08","article-title":"Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.","volume":"76","author":"Huntley","year":"2008","journal-title":"Infect. Immun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/BF02932159","article-title":"Proteomic analysis of antibody response in a case of laboratory-acquired infection with Francisella tularensis subsp. tularensis.","volume":"52","author":"Janovska","year":"2007","journal-title":"Folia Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1515\/BC.2008.064","article-title":"The coming of age of virus-like particle vaccines.","volume":"389","author":"Jennings","year":"2008","journal-title":"Biol. Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1128\/IAI.01013-12","article-title":"A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.","volume":"81","author":"Jia","year":"2013","journal-title":"Infect. Immun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/CVI.05384-11","article-title":"Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.","volume":"19","author":"Kaur","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4161\/viru.1.5.12862","article-title":"IL-17 in protective immunity to intracellular pathogens.","volume":"1","author":"Khader","year":"2010","journal-title":"Virulence"},{"key":"B42","doi-asserted-by":"publisher","first-page":"532","DOI":"10.4049\/jimmunol.179.1.532","article-title":"Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis.","volume":"179","author":"Kirimanjeswara","year":"2007","journal-title":"J. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-065X.2008.00689.x","article-title":"Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis.","volume":"225","author":"Kirimanjeswara","year":"2008","journal-title":"Immunol. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.immuni.2009.08.025","article-title":"Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis.","volume":"31","author":"Lin","year":"2009","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060621","article-title":"Humans have antibodies against a plant virus: evidence from tobacco mosaic virus.","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"25216","DOI":"10.1074\/jbc.M112.367672","article-title":"Identification of a novel Francisella tularensis factor required for intramacrophage survival and subversion of innate immune response.","volume":"287","author":"Mahawar","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061539","article-title":"Identification of a live attenuated vaccine candidate for tularemia prophylaxis.","volume":"8","author":"Mahawar","year":"2013","journal-title":"PLoS One"},{"key":"B48","doi-asserted-by":"publisher","first-page":"586","DOI":"10.4161\/hv.27567","article-title":"Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge.","volume":"10","author":"Mallajosyula","year":"2014","journal-title":"Hum. Vaccin Immunother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size.","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1016\/j.vaccine.2013.05.096","article-title":"Live attenuated tularemia vaccines: recent developments and future goals.","volume":"31","author":"Marohn","year":"2013","journal-title":"Vaccine"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00047","article-title":"CpG-ODN shapes alum adjuvant activity signaling via MyD88 and IL-10.","volume":"8","author":"Mirotti","year":"2017","journal-title":"Front. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4014\/jmb.1707.07075","article-title":"Humanized mice for the evaluation of Francisella tularensis vaccine candidates.","volume":"28","author":"Oh","year":"2017","journal-title":"J. Microbiol. Biotechnol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.4014\/jmb.1602.02022","article-title":"A synthetic Tul4 and FopA peptide cocktail of Francisella tularensis induces humoral and cell-mediated immune responses in mice.","volume":"26","author":"Oh","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"B55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10482-004-6251-7","article-title":"Tularemia vaccine: past, present and future.","volume":"87","author":"Oyston","year":"2005","journal-title":"Antonie Van Leeuwenhoek"},{"key":"B56","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1089\/jir.2009.0108","article-title":"Th17 cytokines in recall responses against Francisella tularensis in humans.","volume":"30","author":"Paranavitana","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"key":"B57","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.4049\/jimmunol.153.3.1238","article-title":"Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages.","volume":"153","author":"Polsinelli","year":"1994","journal-title":"J. Immunol."},{"key":"B58","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1128\/IAI.62.8.3129-3137.1994","article-title":"Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells.","volume":"62","author":"Rhinehart-Jones","year":"1994","journal-title":"Infect. Immun."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00574-16","article-title":"Monophosphoryl lipid A enhances efficacy of a Francisella tularensis LVS-catanionic nanoparticle subunit vaccine against F. tularensis Schu S4 challenge by augmenting both humoral and cellular immunity.","volume":"24","author":"Richard","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1128\/CVI.00738-13","article-title":"Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.","volume":"21","author":"Richard","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1016\/j.vaccine.2014.05.013","article-title":"IFN-gamma, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis live vaccine stain infection.","volume":"32","author":"Roberts","year":"2014","journal-title":"Vaccine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.vaccine.2017.03.064","article-title":"Expansion and retention of pulmonary CD4+ T cells after prime boost vaccination correlates with improved longevity and strength of immunity against tularemia.","volume":"35","author":"Roberts","year":"2017","journal-title":"Vaccine"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1409.009","article-title":"Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations.","volume":"1105","author":"Sjostedt","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0882-4010(92)90025-J","article-title":"The 17 kDa lipoprotein and encoding gene of Francisella tularensis LVS are conserved in strains of Francisella tularensis.","volume":"13","author":"Sjostedt","year":"1992","journal-title":"Microb. Pathog."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1099\/13500872-142-6-1369","article-title":"The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum.","author":"Sjostedt","year":"1996","journal-title":"Microbiology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/0923-2508(90)90126-B","article-title":"Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis. A model for identification of bacterial determinants relevant to the host defence against tularemia.","volume":"141","author":"Sjostedt","year":"1990","journal-title":"Res. Microbiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.virol.2006.08.040","article-title":"Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.","volume":"358","author":"Smith","year":"2007","journal-title":"Virology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.virol.2005.12.039","article-title":"Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.","volume":"348","author":"Smith","year":"2006","journal-title":"Virology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00064-17","article-title":"Protective role for macrophages in respiratory Francisella tularensis infection.","volume":"85","author":"Steiner","year":"2017","journal-title":"Infect. Immun."},{"key":"B70","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/clinids\/11.3.440","article-title":"Nature of protective immunity to Francisella tularensis.","volume":"11","author":"Tarnvik","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/00365540410020442","article-title":"Tularaemia in Europe: an epidemiological overview.","volume":"36","author":"Tarnvik","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.molimm.2009.01.008","article-title":"Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.","volume":"46","author":"Valentino","year":"2009","journal-title":"Mol. Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1128\/IAI.73.5.2644-2654.2005","article-title":"Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.","volume":"73","author":"Wu","year":"2005","journal-title":"Infect. Immun."},{"key":"B74","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10096-007-0434-x","article-title":"The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge.","volume":"27","author":"Yu","year":"2008","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.01195\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T00:00:33Z","timestamp":1693699233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.01195\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":74,"alternative-id":["10.3389\/fmicb.2018.01195"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.01195","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"article-number":"1195"}}